Drug Research
West Makes Minority Investment in Dublin-Based Latch Medical, a...
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical,...
Press Releases
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner, SK bioscience, has received a Post...
Press Releases
Roche announces U.S. FDA approval of Xofluza to treat...
Roche announced that the US FDA has approved a supplemental New Drug Application (sNDA) for Xofluza® (baloxavir marboxil) for the treatment of acute uncomplicated influenza...
Drug Research
Thermo Fisher Announced FDA Approves First NGS-Based Companion Diagnostic...
The U.S. FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors...
Press Releases
Gerresheimer invests up to 94 million Dollar in US...
Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, announced investments to rapidly expand its...
Press Releases
Charles River Receives EMA Approval to Produce Allogeneic Cell...
Charles River Laboratories, International Inc. announced it has received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell...
Drug Research
WuXi Advanced Therapies Announces Licensing Agreement with Janssen
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.